Sana presents preclinical data for in vivo CAR T cell therapy SG293

May 12, 2026 4:05 PM

Sana Biotechnology Inc. (NASDAQ: SANA) presented preclinical data for SG293, an in vivo CAR T cell therapy, at the American ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found